Summary
- Current Price
- As of today, NTRA price is $333.45, up +1.75% in the most recent trading session on
- Current Price All-Time High
- NTRA price is currently -0.73% below its historical high of $335.90 set on
- Market Cap
- NTRA current market cap is $48B, up +116.32% over the past 365 days
- Revenue
- NTRA current annual revenue is $2.31B, up +35.90% year-over-year
- Next Earnings
- The next earnings release for NTRA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Natera, Inc. |
| Ticker | NASDAQ: NTRA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | natera.com |
| Employees | 4,424 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $333.45 | |
| Price, 1D Change | +1.75% | |
| Market Cap | $48B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.26 | |
| Revenue | $2.31B | |
| Revenue, 1Y Change | +35.90% | |
| EPS | -$1.52 | |
| EPS, 1Y Change | +0.28% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$1.52 | |
| EPS Estimate | -$1.41 | N/A |
| EPS Est. Change | +7.59% | N/A |
| Revenue | $2.31B | |
| Revenue Estimate | $2.90B | N/A |
| Revenue Est. Change | +25.74% | N/A |
| Current Price | $333.45 | |
| Price Target | $348.00 | - |
| Price Tgt. Change | +4.36% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.55 | -$1.53 | +1.51% | |
| -$2.42 | -$1.52 | +37.06% | |
| -$1.41 | N/A | +7.59% | |
| -$0.11 | N/A | +92.70% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.63B | $1.70B | +3.98% | |
| $2.24B | $2.31B | +3.04% | |
| $2.90B | N/A | +25.74% | |
| $3.47B | N/A | +50.46% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +105.24% | |
| Price, 3Y | +481.13% | |
| Market Cap, 1Y | +116.32% | |
| Market Cap, 3Y | +634.46% | |
| Revenue, 1Y | +35.90% | |
| Revenue, 3Y | +181.16% | |
| EPS, 1Y | +0.28% | |
| EPS, 3Y | +72.65% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $333.45 | |
| SMA 200 | $229.99 | |
| SMA 50 | $274.82 | |
| EMA 200 | $230.83 | |
| EMA 50 | $277.82 | |
| MACD | $16.79 | |
| Beta | 1.26 | |
| ATR | $12.67 | |
| 14-Day RSI | 68.65 | |
| 10-Day Volatility | 30.64% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $2.31B | |
| EPS | -$1.52 | |
| Gross Profit | $0.00 | |
| Gross Margin | 64.67% | |
| Operating Income | -$306.01M | |
| Operating Margin | -13.27% | |
| Net Income | -$208.16M | |
| Net Margin | -9.03% | |
| EBITDA | -$262.53M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.13 | |
| 3.39 | ||
| 3.24 | ||
| - | ||
| 3 | ||
| 36.12 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 17.76 | ||
| 26.39 | ||
| -214.63 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $1.71B | |
| $1.08B | ||
| $2.51B | ||
| $1.50B | ||
| $795.62M | ||
| $441.23M | ||
| Total Debt | $214.38M | |
| $95.90M | ||
| $33.16M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $2.51B | ||
| $1.80B | ||
| $814.65M | ||
| $1.18B | ||
| $43.48M | ||
| $0.00 | ||
| -$59.93M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $215.30M | ||
| -$132.21M | ||
| $47.46M | ||
| Capex | $139.19M | |
| $76.11M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Citigroup | → | |
| Stephens & Co. | → | |
| Piper Sandler | → | |
| Guggenheim | → | |
| Wells Fargo | → | |
| TD Cowen | → | |
| RBC Capital | → | |
| JP Morgan | → | |
| Evercore ISI Group | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
No data
Screeners with NTRA
FAQ
- What is the ticker symbol for Natera, Inc.?
- The ticker symbol for Natera, Inc. is NASDAQ:NTRA
- Does Natera, Inc. pay dividends?
- No, Natera, Inc. does not pay dividends
- What sector is Natera, Inc. in?
- Natera, Inc. is in the Healthcare sector
- What industry is Natera, Inc. in?
- Natera, Inc. is in the Diagnostics & Research industry
- What country is Natera, Inc. based in?
- Natera, Inc. is headquartered in United States
- When did Natera, Inc. go public?
- Natera, Inc. initial public offering (IPO) was on July 1, 2015
- Is Natera, Inc. in the S&P 500?
- No, Natera, Inc. is not included in the S&P 500 index
- Is Natera, Inc. in the NASDAQ 100?
- No, Natera, Inc. is not included in the NASDAQ 100 index
- Is Natera, Inc. in the Dow Jones?
- No, Natera, Inc. is not included in the Dow Jones index
- When was Natera, Inc. last earnings report?
- Natera, Inc.'s most recent earnings report was on August 6, 2026
- When does Natera, Inc. report earnings?
- The next expected earnings date for Natera, Inc. is November 5, 2026
Data Sources & References
- NTRA Official Website www.natera.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1604821/000110465926020881/0001104659-26-020881-index.htm
- NTRA Profile on Yahoo Finance finance.yahoo.com/quote/NTRA
- NTRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ntra
